Bender James G. 4
4 · ImmunoCellular Therapeutics, Ltd. · Filed Jun 6, 2012
Insider Transaction Report
Form 4
Bender James G.
VP, Product Development & Mfg.
Transactions
- Sale
Common Stock
2012-06-01$3.60/sh−4,900$17,640→ 1,479 total - Sale
Common Stock
2012-06-01$3.61/sh−600$2,166→ 879 total - Sale
Common Stock
2012-06-01$3.59/sh−1,500$5,385→ 6,379 total